Clinical Trials Directory

Trials / Terminated

TerminatedNCT01910129

Neurostimulation to the Vagus Nerve for the Reduction in Frequency of Seizures Associated With Epilepsy

A Randomized, Multi-center, Double-blind, Parallel, Crossover Study of a Non-invasive Neurostimulation to the Vagus Nerve With the gammaCore Device for the Reduction in Frequency of Seizures Associated With Epilepsy.

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
ElectroCore INC · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to see the effects of non-invasive vagal nerve stimulation for the reduction in frequency of seizure associated with epilepsy in subjects 18 or older.

Detailed description

The purpose of the study is to determine the effects of non-invasive vagus nerve stimulation for the reduction in frequency of seizure associated with epilepsy in subjects 18 or older. Subjects will record 4 weeks of baseline seizure activity before being randomized for a period of 8 weeks to receive and active treatment to an active-sham treatment. All subjects will then receive another 8 weeks of active treatment.

Conditions

Interventions

TypeNameDescription
DEVICEgammaCorevagal verve stimulation 3 times a day 8 hours apart

Timeline

Start date
2013-07-01
Primary completion
2014-07-01
Completion
2014-10-01
First posted
2013-07-29
Last updated
2019-04-23
Results posted
2019-04-23

Locations

2 sites across 1 country: Australia

Source: ClinicalTrials.gov record NCT01910129. Inclusion in this directory is not an endorsement.